Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Clinical trial NCT05304169 · COMPLETED
Trial details
- NCT number
- NCT05304169
- Sponsor
- Zodiac Produtos Farmaceuticos S.A.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2018-06-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.